Report Detail

Medical Devices & Consumables Global Intelligent Insulin Injection Pens Market Growth 2022-2028

  • RnM4488411
  • |
  • 30 August, 2022
  • |
  • Global
  • |
  • 97 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Devices & Consumables

The global market for Intelligent Insulin Injection Pens is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Intelligent Insulin Injection Pens market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Intelligent Insulin Injection Pens market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Intelligent Insulin Injection Pens market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Intelligent Insulin Injection Pens market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Intelligent Insulin Injection Pens players cover Companion Medical, Novo Nordisk A/S, Diamesco, Insulet Corporation and Emperra GmbH E-Health Technologies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Intelligent Insulin Injection Pens market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Intelligent Insulin Injection Pens market, with both quantitative and qualitative data, to help readers understand how the Intelligent Insulin Injection Pens market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Intelligent Insulin Injection Pens market and forecasts the market size by Type (Smart Insulin Pen and Smart Insulin Pen Cap,), by Application (Hospitals, Home Care and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Smart Insulin Pen
Smart Insulin Pen Cap

Segmentation by application
Hospitals
Home Care
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Companion Medical
Novo Nordisk A/S
Diamesco
Insulet Corporation
Emperra GmbH E-Health Technologies
Jiangsu Delfu Medical Device
Bigfoot Biomedica
Dnurse
·

Chapter Introduction
Chapter 1: Scope of Intelligent Insulin Injection Pens, Research Methodology, etc.
Chapter 2: Executive Summary, global Intelligent Insulin Injection Pens market size (sales and revenue) and CAGR, Intelligent Insulin Injection Pens market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Intelligent Insulin Injection Pens sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Intelligent Insulin Injection Pens sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Intelligent Insulin Injection Pens market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Companion Medical, Novo Nordisk A/S, Diamesco, Insulet Corporation, Emperra GmbH E-Health Technologies, Jiangsu Delfu Medical Device, Bigfoot Biomedica and Dnurse, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Intelligent Insulin Injection Pens Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Intelligent Insulin Injection Pens by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Intelligent Insulin Injection Pens by Country/Region, 2017, 2022 & 2028
  • 2.2 Intelligent Insulin Injection Pens Segment by Type
    • 2.2.1 Smart Insulin Pen
    • 2.2.2 Smart Insulin Pen Cap
  • 2.3 Intelligent Insulin Injection Pens Sales by Type
    • 2.3.1 Global Intelligent Insulin Injection Pens Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Intelligent Insulin Injection Pens Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Intelligent Insulin Injection Pens Sale Price by Type (2017-2022)
  • 2.4 Intelligent Insulin Injection Pens Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Home Care
    • 2.4.3 Others
  • 2.5 Intelligent Insulin Injection Pens Sales by Application
    • 2.5.1 Global Intelligent Insulin Injection Pens Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Intelligent Insulin Injection Pens Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Intelligent Insulin Injection Pens Sale Price by Application (2017-2022)

3 Global Intelligent Insulin Injection Pens by Company

  • 3.1 Global Intelligent Insulin Injection Pens Breakdown Data by Company
    • 3.1.1 Global Intelligent Insulin Injection Pens Annual Sales by Company (2020-2022)
    • 3.1.2 Global Intelligent Insulin Injection Pens Sales Market Share by Company (2020-2022)
  • 3.2 Global Intelligent Insulin Injection Pens Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Intelligent Insulin Injection Pens Revenue by Company (2020-2022)
    • 3.2.2 Global Intelligent Insulin Injection Pens Revenue Market Share by Company (2020-2022)
  • 3.3 Global Intelligent Insulin Injection Pens Sale Price by Company
  • 3.4 Key Manufacturers Intelligent Insulin Injection Pens Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Intelligent Insulin Injection Pens Product Location Distribution
    • 3.4.2 Players Intelligent Insulin Injection Pens Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Intelligent Insulin Injection Pens by Geographic Region

  • 4.1 World Historic Intelligent Insulin Injection Pens Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Intelligent Insulin Injection Pens Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Intelligent Insulin Injection Pens Annual Revenue by Geographic Region
  • 4.2 World Historic Intelligent Insulin Injection Pens Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Intelligent Insulin Injection Pens Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Intelligent Insulin Injection Pens Annual Revenue by Country/Region
  • 4.3 Americas Intelligent Insulin Injection Pens Sales Growth
  • 4.4 APAC Intelligent Insulin Injection Pens Sales Growth
  • 4.5 Europe Intelligent Insulin Injection Pens Sales Growth
  • 4.6 Middle East & Africa Intelligent Insulin Injection Pens Sales Growth

5 Americas

  • 5.1 Americas Intelligent Insulin Injection Pens Sales by Country
    • 5.1.1 Americas Intelligent Insulin Injection Pens Sales by Country (2017-2022)
    • 5.1.2 Americas Intelligent Insulin Injection Pens Revenue by Country (2017-2022)
  • 5.2 Americas Intelligent Insulin Injection Pens Sales by Type
  • 5.3 Americas Intelligent Insulin Injection Pens Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Intelligent Insulin Injection Pens Sales by Region
    • 6.1.1 APAC Intelligent Insulin Injection Pens Sales by Region (2017-2022)
    • 6.1.2 APAC Intelligent Insulin Injection Pens Revenue by Region (2017-2022)
  • 6.2 APAC Intelligent Insulin Injection Pens Sales by Type
  • 6.3 APAC Intelligent Insulin Injection Pens Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Intelligent Insulin Injection Pens by Country
    • 7.1.1 Europe Intelligent Insulin Injection Pens Sales by Country (2017-2022)
    • 7.1.2 Europe Intelligent Insulin Injection Pens Revenue by Country (2017-2022)
  • 7.2 Europe Intelligent Insulin Injection Pens Sales by Type
  • 7.3 Europe Intelligent Insulin Injection Pens Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Intelligent Insulin Injection Pens by Country
    • 8.1.1 Middle East & Africa Intelligent Insulin Injection Pens Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Intelligent Insulin Injection Pens Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Intelligent Insulin Injection Pens Sales by Type
  • 8.3 Middle East & Africa Intelligent Insulin Injection Pens Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Intelligent Insulin Injection Pens
  • 10.3 Manufacturing Process Analysis of Intelligent Insulin Injection Pens
  • 10.4 Industry Chain Structure of Intelligent Insulin Injection Pens

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Intelligent Insulin Injection Pens Distributors
  • 11.3 Intelligent Insulin Injection Pens Customer

12 World Forecast Review for Intelligent Insulin Injection Pens by Geographic Region

  • 12.1 Global Intelligent Insulin Injection Pens Market Size Forecast by Region
    • 12.1.1 Global Intelligent Insulin Injection Pens Forecast by Region (2023-2028)
    • 12.1.2 Global Intelligent Insulin Injection Pens Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Intelligent Insulin Injection Pens Forecast by Type
  • 12.7 Global Intelligent Insulin Injection Pens Forecast by Application

13 Key Players Analysis

  • 13.1 Companion Medical
    • 13.1.1 Companion Medical Company Information
    • 13.1.2 Companion Medical Intelligent Insulin Injection Pens Product Offered
    • 13.1.3 Companion Medical Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Companion Medical Main Business Overview
    • 13.1.5 Companion Medical Latest Developments
  • 13.2 Novo Nordisk A/S
    • 13.2.1 Novo Nordisk A/S Company Information
    • 13.2.2 Novo Nordisk A/S Intelligent Insulin Injection Pens Product Offered
    • 13.2.3 Novo Nordisk A/S Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Novo Nordisk A/S Main Business Overview
    • 13.2.5 Novo Nordisk A/S Latest Developments
  • 13.3 Diamesco
    • 13.3.1 Diamesco Company Information
    • 13.3.2 Diamesco Intelligent Insulin Injection Pens Product Offered
    • 13.3.3 Diamesco Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Diamesco Main Business Overview
    • 13.3.5 Diamesco Latest Developments
  • 13.4 Insulet Corporation
    • 13.4.1 Insulet Corporation Company Information
    • 13.4.2 Insulet Corporation Intelligent Insulin Injection Pens Product Offered
    • 13.4.3 Insulet Corporation Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Insulet Corporation Main Business Overview
    • 13.4.5 Insulet Corporation Latest Developments
  • 13.5 Emperra GmbH E-Health Technologies
    • 13.5.1 Emperra GmbH E-Health Technologies Company Information
    • 13.5.2 Emperra GmbH E-Health Technologies Intelligent Insulin Injection Pens Product Offered
    • 13.5.3 Emperra GmbH E-Health Technologies Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Emperra GmbH E-Health Technologies Main Business Overview
    • 13.5.5 Emperra GmbH E-Health Technologies Latest Developments
  • 13.6 Jiangsu Delfu Medical Device
    • 13.6.1 Jiangsu Delfu Medical Device Company Information
    • 13.6.2 Jiangsu Delfu Medical Device Intelligent Insulin Injection Pens Product Offered
    • 13.6.3 Jiangsu Delfu Medical Device Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Jiangsu Delfu Medical Device Main Business Overview
    • 13.6.5 Jiangsu Delfu Medical Device Latest Developments
  • 13.7 Bigfoot Biomedica
    • 13.7.1 Bigfoot Biomedica Company Information
    • 13.7.2 Bigfoot Biomedica Intelligent Insulin Injection Pens Product Offered
    • 13.7.3 Bigfoot Biomedica Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Bigfoot Biomedica Main Business Overview
    • 13.7.5 Bigfoot Biomedica Latest Developments
  • 13.8 Dnurse
    • 13.8.1 Dnurse Company Information
    • 13.8.2 Dnurse Intelligent Insulin Injection Pens Product Offered
    • 13.8.3 Dnurse Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Dnurse Main Business Overview
    • 13.8.5 Dnurse Latest Developments
  • 13.9 ·
    • 13.9.1 · Company Information
    • 13.9.2 · Intelligent Insulin Injection Pens Product Offered
    • 13.9.3 · Intelligent Insulin Injection Pens Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 · Main Business Overview
    • 13.9.5 · Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Intelligent Insulin Injection Pens. Industry analysis & Market Report on Intelligent Insulin Injection Pens is a syndicated market report, published as Global Intelligent Insulin Injection Pens Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Intelligent Insulin Injection Pens market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,407.46
6,814.92
3,806.40
7,612.80
528,321.00
1,056,642.00
298,326.60
596,653.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report